Found: 85
Select item for more details and to access through your institution.
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1358, doi. 10.1002/ajh.25256
- By:
- Publication type:
- Article
Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 10, p. 688, doi. 10.1002/ajh.21510
- By:
- Publication type:
- Article
Aggressive Langerhans cell histiocytosis following T-ALL: Clonally related neoplasms with persistent expression of constitutively active NOTCH1.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 2, p. 116, doi. 10.1002/ajh.21044
- By:
- Publication type:
- Article
Case Report Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge.
- Published in:
- Pediatric Allergy & Immunology, 2003, v. 14, n. 5, p. 409, doi. 10.1034/j.1399-3038.2003.00073.x
- By:
- Publication type:
- Article
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.
- Published in:
- Nature Communications, 2014, v. 5, n. 3, p. 3469, doi. 10.1038/ncomms4469
- By:
- Publication type:
- Article
Double Esterase Staining andOther Neutrophilic Granule Abnormalities in 237 Patients with the Myelodysplastic Syndrome Studied by the Cancer and Leukemia Group B.
- Published in:
- Acta Haematologica, 1998, v. 100, n. 1, p. 13, doi. 10.1159/000040855
- By:
- Publication type:
- Article
An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Letter
ALL-167: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S271, doi. 10.1016/S2152-2650(21)01656-6
- By:
- Publication type:
- Article
Poster: ALL-167: A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S209, doi. 10.1016/S2152-2650(21)01310-0
- By:
- Publication type:
- Article
Forsaken Pharmaceutical: Glasdegib in Acute Myeloid Leukemia and Myeloid Diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
TREATMENT RESPONSE WORKSHEET (TRW), A TOOL FOR NURSES IN MANAGING AND EVALUATING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) RECEIVING AZACITIDINE TREATMENT.
- Published in:
- Oncology Nursing Forum, 2006, v. 33, n. 2, p. 438
- By:
- Publication type:
- Article
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 10, p. 1179, doi. 10.1093/jnci/djad099
- By:
- Publication type:
- Article
Clinical Significance of Cytogenetic Manifestations in Myelodysplastic Syndromes.
- Published in:
- Laboratory Medicine, 2013, v. 44, n. 2, p. 103, doi. 10.1309/LMSZ0MFKXTY4PGL1
- By:
- Publication type:
- Article
Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository.
- Published in:
- Metabolomics, 2021, v. 17, n. 7, p. 1, doi. 10.1007/s11306-021-01814-2
- By:
- Publication type:
- Article
The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 4, p. 452, doi. 10.1111/j.1365-2141.2010.08524.x
- By:
- Publication type:
- Article
Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 2, p. 185, doi. 10.1111/j.1365-2141.2005.05754.x
- By:
- Publication type:
- Article
Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 159, doi. 10.1634/theoncologist.2017-0215
- By:
- Publication type:
- Article
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 130, doi. 10.1111/j.1600-0609.2010.01456.x
- By:
- Publication type:
- Article
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 5, p. 385, doi. 10.1007/s11899-016-0337-y
- By:
- Publication type:
- Article
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 421, doi. 10.1111/bjh.18093
- By:
- Publication type:
- Article
The impact of comparative genomic hybridization/single‐nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31129
- By:
- Publication type:
- Article
Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30560
- By:
- Publication type:
- Article
"There's no playbook for when your kid has cancer": Desired elements of an electronic resource to support pediatric cancer communication.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 3, p. 1, doi. 10.1002/pbc.30198
- By:
- Publication type:
- Article
Reply to: Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 1, p. 1, doi. 10.1002/pbc.29833
- By:
- Publication type:
- Article
Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 11, p. 1, doi. 10.1002/pbc.29933
- By:
- Publication type:
- Article
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR).
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 11, p. 1, doi. 10.1002/pbc.29901
- By:
- Publication type:
- Article
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29581
- By:
- Publication type:
- Article
Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 7, p. 1, doi. 10.1002/pbc.29505
- By:
- Publication type:
- Article
Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 1, p. 1, doi. 10.1002/pbc.28574
- By:
- Publication type:
- Article
How we approach Philadelphia chromosome-positive acute lymphoblastic leukemia in children and young adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Divide and conquer: Evaluation of a redesign of a pediatric teaching service.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- letter
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 3, p. 1, doi. 10.1002/pbc.26871
- By:
- Publication type:
- Article
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1232, doi. 10.1002/pbc.24938
- By:
- Publication type:
- Article
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1785, doi. 10.1002/pbc.24666
- By:
- Publication type:
- Article
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 344, doi. 10.1002/pbc.24354
- By:
- Publication type:
- Article
Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 5, p. 925, doi. 10.1002/pbc.24182
- By:
- Publication type:
- Article
Health-related quality of life among children with acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 717, doi. 10.1002/pbc.24096
- By:
- Publication type:
- Article
Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 5, p. 758, doi. 10.1002/pbc.23234
- By:
- Publication type:
- Article